Study documents: Imatinib Concentration Monitoring Evaluation (I-COME)

A Study to Compare the Clinical Usefulness of «Routine» versus «Rescue» Therapeutic Drug Monitoring (TDM) Interventions in Chronic Myeloid Leukemia (CML) Patients

You can find below every documents related to this study:

      1. Study summary & information to recruiting physicians:

English	Français	Deutsch	Italiano
Summary	Résumé	Übersicht
Presentation (slides)	Lettre d'information	Informationsbrief	Lettera d'informazione

The study has been approved by local Ethics Committees for the following Swiss cantons: see Approval paragraph.

      2. Inclusion documents:

a) Blood measurement request form (serving as case reprot form, CRF)

Bon de demande de dosage / Formular zur Plasmaspiegelmessung

b) Patient information & consent form

Français	Deutsch	Italiano
Information aux patients	Patienteninformtation	Informazione per i pazienti
Consentement	Einverständniserklärung	Consenso informato

c) Invoice example (for administrative work associated with the study)

Facture-type      Rechnungsvorlage

Contact

Verena Gotta
I-COME coordinator
Division of Clinical Pharmacology and Toxicology
Centre Hospitalier Universitaire Vaudois – CHUV
1011 Lausanne – SWITZERLAND